Case Report

A Case of Vaping TCH Oil Leading to Vaping Associated Pulmonary Injury: Our Approach to Its Diagnosis, Management, and Recommendations

Table 1

Infectious and autoimmune labs tested.

Significant labPatient’s lab resultsLab reference range

IGE1900 IU/ml0–100 IU/ml
IGG666 mg/dl700–1600 mg/dl
IGM143 mg/dl40–230 mg/dl
IGA180 mg/dl70–400 mg/dl
CRP26.2 mg/dl<0.3 mg/dl
ESR69 mm/hr0–10 mm/hr
Procalcitonin0.30 ng/ml<0.05 ng/ml
Lactate dehydrogenase234 IU/L87–241 IU/ml
Urine cannabinoidsPositiveThreshold 50 ng/ml
ANA screenNegative
Scl-70<1.0 AI
C3125 mg/dl90–180 mg/dl
C426.6 mg/dl10–40 mg/dl
RA<10 IU/dl=<15 IU/dl
Cyclic citrullinated peptide16Weak positive: 20–39
ANCANegative p-anca, c-anca, atypical anca
CryoglobulinsNone detected
Glom basement Membrane IGG<1.0 AI
AFB culture and smearNegative
Fungus culture and smearNegative
Legionella cultureNegative
Pneumocystis smearNegative
Lower respiratory cultureNegative
S. pneumoniae Antigen urineNegative
Urine cultureNegative
Influenza A/B antigenNegative
RP panelNegative
HIV Ab/Ag, 4th genNonreactive